<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>PURPOSE: To assess the role of <z:chebi fb="4" ids="30225">positron</z:chebi> emission tomography-computed tomography (PET-CT) and multidetector-row CT (MD-CT) in detecting the <z:e sem="disease" ids="C1402294" disease_type="Disease or Syndrome" abbrv="">primary lesion</z:e> and lymph node <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastasis</z:e> in patients with <z:e sem="disease" ids="C1527249" disease_type="Neoplastic Process" abbrv="">colorectal cancers</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>METHODS: A collective total of 80 lesions resected from 77 patients were examined pathologically </plain></SENT>
<SENT sid="2" pm="."><plain>We analyzed the significance of the standardized uptake value (SUV) and its relationship with the clinicopathologic findings of <z:e sem="disease" ids="C1402294" disease_type="Disease or Syndrome" abbrv="">primary lesions</z:e> and lymph node <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastasis</z:e> </plain></SENT>
<SENT sid="3" pm="."><plain>The detectability of <z:e sem="disease" ids="C1402294" disease_type="Disease or Syndrome" abbrv="">primary lesions</z:e> and <z:e sem="disease" ids="C0686619" disease_type="Neoplastic Process" abbrv="">lymph node metastases</z:e> on PET-CT images was compared with that on MD-CT images </plain></SENT>
<SENT sid="4" pm="."><plain>RESULTS: The detectability of <z:e sem="disease" ids="C1402294" disease_type="Disease or Syndrome" abbrv="">primary lesions</z:e> was better on PET-CT images than on MD-CT images (p = 0.0023) </plain></SENT>
<SENT sid="5" pm="."><plain>We observed no significant differences in the SUV with respect to staging, <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> grade, lymphatic or vessel invasion, and macroscopic type; however, <z:e sem="disease" ids="C0677930" disease_type="Neoplastic Process" abbrv="">primary tumor</z:e> size analysis revealed that <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> larger than 3 cm had a higher SUV than those smaller than 3 cm </plain></SENT>
<SENT sid="6" pm="."><plain>The sensitivity of PET-CT for detecting lymph node <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastasis</z:e> was lower than that of MD-CT, but the specificity of PET-CT was higher than that of MD-CT </plain></SENT>
<SENT sid="7" pm="."><plain>CONCLUSIONS: The SUV of primary <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancers</z:e> tends to increase in proportion to <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> size </plain></SENT>
<SENT sid="8" pm="."><plain>Although the value of PET-CT in detecting lymph node <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastasis</z:e> is limited, PET -positive lymph nodes can be considered metastatic </plain></SENT>
</text></document>